Is this you?
Request access for Texas Institute of Cardiology with your @bitrialsupport.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall80Recruit65Ops84Sponsor93Ther83
Performance (observed)
Historical trials
521
Completed
320
Terminated/Withdrawn
52
Completion rate
86%
Active now
135
Phase 2
69
Phase 3
254
Realized enrollment
1,097,871
First study year
1998
Years active
28
Match confidence
high
Enrollment velocity (inf)
39,210
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
378
States
Texas
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Abbott Medical Devices; Boston Scientific Corporation; Pfizer; Novo Nordisk A/S; Boehringer Ingelheim; Actelion
CROs
ABX CRO; ICON plc; IQVIA Biotech; IQVIA Pty Ltd; Medpace, Inc.; MicroPort CRM
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
unitedstates@bitrialsupport.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall80
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.